Altered Peripheral and Central Inflammatory Responses in a Mouse Model of Autism

Autism Research

Volumn 7, Issue 2, 2014, Pages 273-289

  Lucchina, Luciana ^a,b   Depino, Amaicha Mara ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Astroglia; Behavior; Cytokines; Hypothalamus pituitary adrenal axis; Microglia; Valproic acid

Indexed keywords

CORTICOSTERONE; CYTOKINE; LIPOPOLYSACCHARIDE; VALPROIC ACID; AUTACOID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CEREBELLUM; CONTROLLED STUDY; CORTICOSTERONE RELEASE; ELEVATED PLUS MAZE TEST; FEMALE; GLIA; HIPPOCAMPUS; MALE; MICROGLIAL CELL CULTURE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SOCIAL INTERACTION; SPLEEN; ANIMAL; BIOLOGICAL MODEL; BLOOD; CHEMICALLY INDUCED; IMMUNOLOGY; PREGNANCY; PRENATAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CEREBELLUM; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CORTICOSTERONE; CYTOKINES; FEMALE; HIPPOCAMPUS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MODELS, GENETIC; NEUROGLIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REAL-TIME POLYMERASE CHAIN REACTION; VALPROIC ACID;

EID: 84898877564     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1338     Document Type: Article

References (52)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, text revision, (4th ed.). Washington, DC: American Psychiatric Association.
2. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011). Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 25, 40-45.
3. Banbury Conference. (1997). Mutant mice and neuroscience: Recommendations concerning genetic background. Banbury conference on genetic background in mice. Neuron, 19, 755-759.
4. Carola, V., Frazzetto, G., & Gross, C. (2006). Identifying interactions between genes and early environment in the mouse. Genes, Brain, and Behavior, 5, 189-199.
5. Centers for Disease Control and Prevention. (2009). Prevalence of autism spectrum disorders-Autism and developmental disabilities monitoring network, United States, 2006, surveillance summaries, MMWR.
6. Corbett, B.A., Mendoza, S., Abdullah, M., Wegelin, J.A., & Levine, S. (2006). Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology, 31, 59-68.
7. Courchesne, E., Yeung-Courchesne, R., Press, G.A., Hesselink, J.R., & Jernigan, T.L. (1988). Hypoplasia of cerebellar vermal lobules VI and VII in autism. The New England Journal of Medicine, 318, 1349-1354.
8. Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., & Maes, M. (2002). Activation of the inflammatory response system in autism. Neuropsychobiology, 45, 1-6.
9. Cryan, J.F., & Mombereau, C. (2004). In search of a depressed mouse: Utility of models for studying depression-related behavior in genetically modified mice. Molecular Psychiatry, 9, 326-357.
10. DeLorey, T.M., Sahbaie, P., Hashemi, E., Homanics, G.E., & Clark, J.D. (2008). Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: A potential model of autism spectrum disorder. Behavioural Brain Research, 187, 207-220.
11. Depino, A., Ferrari, C., Pott Godoy, M.C., Tarelli, R., & Pitossi, F.J. (2005). Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions. Journal of Neuroimmunology, 168, 96-110.
12. Depino, A.M. (2013). Peripheral and central inflammation in autism spectrum disorders. Molecular and Cellular Neurosciences, 53, 69-76.
13. Depino, A.M., Lucchina, L., & Pitossi, F. (2011). Early and adult hippocampal TGF-beta1 overexpression have opposite effects on behavior. Brain, Behavior, and Immunity, 25, 1582-1591.
14. Depino, A.M., Tsetsenis, T., & Gross, C. (2008). GABA homeostasis contributes to the developmental programmin g of anxiety-related behavior. Brain Research, 1210, 189-199.
15. Enstrom, A.M., Onore, C.E., Van de Water, J.A., & Ashwood, P. (2010). Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain, Behavior, and Immunity, 24, 64-71.
16. Garbett, K., Ebert, P.J., Mitchell, A., Lintas, C., Manzi, B., etal. (2008). Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiology of Disease, 30, 303-311.
17. Hofvander, B., Delorme, R., Chaste, P., Nyden, A., Wentz, E., etal. (2009). Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry, 9: 35. doi: 10.1186/1471-244X-9-35
18. Hornig, M., Briese, T., Buie, T., Bauman, M.L., Lauwers, G., etal. (2008). Lack of association between measles virus vaccine and autism with enteropathy: A case-control study. PLoS ONE, 3, e3140. doi:10.1371/journal.pone.0003140
19. Howard, C.V., & Reed, M.G. (2005). Unbiased stereology. New York: Garland Science/BIOS Scientific.
20. Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K., & Patterson, P.H. (2012). Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proceedings of the National Academy of Sciences of the United States of America, 109, 12776-12781.
21. Jyonouchi, H., Sun, S., & Le, H. (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology, 120, 170-179.
22. Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013). Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. The International Journal of Neuropsychopharmacology, 16, 91-103.
23. Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Yang, S.I., etal. (2011). The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicology Letters, 201, 137-142.
24. Kreutzberg, G.W. (1996). Microglia: A sensor for pathological events in the CNS. Trends in Neurosciences, 19, 312-318.
25. Lainhart, J. (1999). Psychiatric problems in individuals with autism, their parents and siblings. International Review of Psychiatry, 11, 278-298.
26. Lucchina, L., Carola, V., Pitossi, F., & Depino, A.M. (2010). Evaluating the interaction between early postnatal inflammation and maternal care in the programming of adult anxiety and depression-related behaviors. Behavioural Brain Research, 213, 56-65.
27. Malik, M., Sheikh, A.M., Wen, G., Spivack, W., Brown, W.T., & Li, X. (2011). Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology, 216, 80-85.
28. Malkova, N.V., Yu, C.Z., Hsiao, E.Y., Moore, M.J., & Patterson, P.H. (2012). Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain, Behavior, and Immunity, 26, 607-616.
29. Martin, L.A., Goldowitz, D., & Mittleman, G. (2010). Repetitive behavior and increased activity in mice with Purkinje cell loss: A model for understanding the role of cerebellar pathology in autism. The European Journal of Neuroscience, 31, 544-555.
30. McCusker, R.H., & Kelley, K.W. (2013). Immune-neural connections: How the immune system's response to infectious agents influences behavior. The Journal of Experimental Biology, 216, 84-98.
31. Moore, S.J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D.J., etal. (2000). A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics, 37, 489-497.
32. Morgan, J.T., Chana, G., Pardo, C.A., Achim, C., Semendeferi, K., etal. (2010). Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biological Psychiatry, 68, 368-376.
33. Onore, C., Careaga, M., & Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity, 26, 383-392.
34. Parracho, H.M., Bingham, M.O., Gibson, G.R., & McCartney, A.L. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology, 54, 987-991.
35. Patterson, P.H. (2011). Maternal infection and immune involvement in autism. Trends in Molecular Medicine, 17, 389-394.
36. Paxinos, G., & Franklin, K. (2001). The mouse brain in stereotaxic coordinates (2nd ed.). San Diego: Academic Press.
37. Pitossi, F., del Rey, A., Kabiersch, A., & Besedovsky, H. (1997). Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. Journal of Neuroscience Research, 48, 287-298.
38. Rasband, W.S. (1997-2009). ImageJ. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/.
39. Rutter, M. (2005). Incidence of autism spectrum disorders: Changes over time and their meaning. Acta Paediatrica, 94, 2-15.
40. Schneider, T., & Przewlocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology, 30, 80-89.
41. Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., etal. (2008). Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology, 33, 728-740.
42. Shanks, N., Windle, R.J., Perks, P.A., Harbuz, M.S., Jessop, D.S., etal. (2000). Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proceedings of the National Academy of Sciences of the United States of America, 97, 5645-5650.
43. Shi, L., Smith, S.E., Malkova, N., Tse, D., Su, Y., & Patterson, P.H. (2009). Activation of the maternal immune system alters cerebellar development in the offspring. Brain, Behavior, and Immunity, 23, 116-123.
44. Spratt, E.G., Nicholas, J.S., Brady, K.T., Carpenter, L.A., Hatcher, C.R., etal. (2012). Enhanced cortisol response to stress in children in autism. Journal of Autism and Developmental Disorders, 42, 75-81.
45. Stewart, M.E., Barnard, L., Pearson, J., Hasan, R., & O'Brien, G. (2006). Presentation of depression in autism and Asperger syndrome: A review. Autism, 10, 103-116.
46. Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., etal. (2013). Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry, 70, 49-58.
47. Tetreault, N.A., Hakeem, A.Y., Jiang, S., Williams, B.A., Allman, E., etal. (2012). Microglia in the cerebral cortex in autism. Journal of Autism and Developmental Disorders, 42, 2569-2584.
48. Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., & Pardo, C.A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81.
49. Wagner, G.C., Reuhl, K.R., Cheh, M., McRae, P., & Halladay, A.K. (2006). A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate. Journal of Autism and Developmental Disorders, 36, 779-793.
50. Wang, L.W., Tancredi, D.J., & Thomas, D.W. (2011). The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. Journal of Developmental and Behavioral Pediatrics, 32, 351-360.
51. West, M.J., Slomianka, L., & Gundersen, H.J. (1991). Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. The Anatomical Record, 231, 482-497.
52. Yirmiya, R., & Goshen, I. (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behavior, and Immunity, 25, 181-213.